Choose a language
EVE attaches great importance to your personal privacy. When you visit our website, please agree to the use of all cookies. More information about the processing of personal data can be found at "Privacy Policy"
Choose a language
.png)
See the latest data on EVE's financial, environmental and social performance
| Indicator | Unit | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | RMB 100 million | 1008.91 | 943.55 | 836.38 |
| Operating revenue | RMB 100 million | 486.15 | 487.84 | 363.04 |
| Net profit attributable to shareholders of the listed company | RMB 100 million | 40.76 | 40.50 | 35.09 |
| Basic earnings per share (EPS) | RMB per share | 1.99 | 1.98 | 1.84 |
| Employee compensation payable | RMB 100 million | 6.63 | 6.73 | 6.05 |
| Indicator | Unit | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Number of directors | Person | 7 | 7 | 7 |
| Number of independent directors | Person | 3 | 3 | 3 |
| Num ber of female directors | Person | 2 | 2 | 2 |
| Proportion of independent directors | % | 42.86 | 42.86 | 42.86 |
| Proportion of female directors on the board | % | 28.57 | 28.57 | 28.57 |
| Number of board meetings held | nos | 19 | 21 | 19 |
| Number of general shareholders' meetings held | nos | 7 | 10 | 7 |
| Number of supervisory board meetings held | nos | 18 | 20 | 19 |
| Indicator | Unit | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Number of operations assessed for risks related to corruption | % | 100 | 100 | / |
| Number of confirmed incidents of corruption during the reporting period | nos | 6 | 1 | 2 |
| Total number of confirmed incidents when contracts with business partners were terminated or not renewed due to violations related to corruption | nos | 0 | 0 | / |
| Percentage of directors receiving anti-bribery and anti-corruption training | % | 72.73 | 9.09 | / |
| Percentage of management personnel receiving anti-bribery and anti-corruption training | % | 36 | 32.24 | / |
| Percentage of employees receiving anti-bribery and anti-corruption training | % | 100 | 9.89 | / |
| Employee anti-corruption training coverage rate | % | 100 | 100 | 100 |
| Number of anti-corruption training sessions for management | nos | 20 | 7 | / |
| Number of lawsuits related to unfair competition and violations of anti-trust and anti-monopoly law | nos | 0 | 0 | / |
| Amount involved in lawsuits or major administrative penalties due to the Company’s unfair | RMB | 0 | 0 | 0 |
| Indicator | Unit | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total R&D investment | RMB 100 million | 30.6 | 28.71 | 22.61 |
| R&D investment as a percentage of operating revenue | % | 6.29 | 5.88 | 6.23 |
| Number of R&D employees | Person | 6,068 | 5,291 | 4,192 |
| R&D employees with PhD holders | Person | 56 | 43 | 42 |
| R&D employees with Master‘s degree holders | Person | 1,576 | 1,243 | 920 |
| Cumulative national patent applications | nos | 10,007 | 7,430 | 4,627 |
| Cumulative granted patents | nos | 6,293 | 4,925 | 3,286 |
Explanation on statistical scope and calculation methods:
The statistical scope of the Company's economic and governance data is consistent with the scope of its consolidated financial statements.
